Clinical Trial

Describing Treatment Patterns and Creating an Updated Treatment Flow in an Ulcerative Colitis Population

Study acronym: EFFECT-1LAT
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 14, 2026 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
Describing Treatment Patterns and Creating an Updated Treatment Flow in an Ulcerative Colitis Population
Protocol Amendment History 4 changes
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-05-15
critical Recruitment opened 2026-04-28
notable Primary completion pushed: 2026-05-31 -> 2026-07-31 2026-04-14
minor Completion pushed: 2026-05-31 -> 2026-07-31 2026-04-14
Trial Details
NCT Number NCT07177209
Lead Sponsor Pfizer
Conditions Ulcerative Colitis
Enrollment 4,000 participants
Start Date 2026-04-01
Primary Completion 2026-07-31 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-14